Adedinsewo DA, Noory L, Badnarczyk RA, et al. Impact of maternal characteristics on the effect of maternal influenza vaccination on fetal outcomes. Vaccine 2013 (published online Oct 10)
Ahmed F, Lindley MC, Allred Norma, et al. Effect of influenza vaccination of health care personnel on morbidity and mortality among patients: systematic review and grading of evidence. Clin Infect Dis 2013 (published online Sep 17)
Ambrose CS, Dubovsky F, Yi T, et al. The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing. Eur J Clin Microbiol Infect Dis 2012 Oct;31(10):2549-57
Baguelin M, Flasche S, Camacho A, et al. Assessing optimal target populations for influenza vaccination programs: an evidence synthesis and modeling study. PLoS Med 2013 Oct 8;10(10):e1001527
Bateman AX, Kieke BA, Irving SA, et al. Effectiveness of monovalent A(H1N1)pdm09 and 2010-11 trivalent inactivated influenza vaccines in Wisconsin during the 2010-11 season. J Infect Dis 2013 Apr 15;207(8):1262-9
Bednarczyk RA, Adjaye-Gbewonyo D, Omer SB. Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol 2012 Sep;207(3 Suppl):S38-46
Benchimol EI, Hawken S, Kwong JC, et al. Safety and utilization of influenza immunization in children with inflammatory bowel disease. Pediatrics 2013 (published online May 6)
Block SL, Falloon J, Hirschfield JA, et al The immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children. Pediatr Infect Dis J 2012 Jul;31(7):745-51
Bodewes R, Fraaij PLA, Kreijtz JHCM, et al. Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine 2012 Dec 7;30(51):7407-10
Bonmarin I, Belchior E, Strat YL, et al. First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12. Euro Surveill 2012 May 3;17(18):pii=20163
Bragstad K, Emborg HD, Fischer TK, et al. Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13 -- a rapid epidemiological and virological assessment. Euro Surveill 2013 Feb 7;18(6):pii=20397
Burwen DR, Sandhu SK, McCurdy TE, et al. Surveillance for Guillain-Barre syndrome after influenza vaccination among the Medicare population, 2009-2010. Am J Public Health 2012 Oct;102(10):1921-7
Burwen DR, Sandhu SK, McCurdy TE, et al. Surveillance for Guillain-Barre syndrome after influenza vaccination among the Medicare population, 2009-2010. Am J Public Health 2012 Oct;102(10):1921-7
Castilla J, Godoy P, Dominguez A, et al. Influenza vaccine effectiveness in preventing out-patient, in-patient and severe cases of laboratory-confirmed influenza. Clin Infect Dis 2013 Jul 15;57(2):167-75
Castilla J, Martinez-Baz I, Martinez-Artola V, et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013 Jan 31;18(5):pii=20388
Castilla J, Martinez-Baz I, Martinez-Artola V, et al. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveill 2013 Feb 14;18(7):pii=20404
CDC. Influenza vaccination coverage among adults--National Health Interview Survey, United States, 2008-09 influenza season. MMWR 2012 Jun 15;61(2):65-72
CDC. Influenza vaccination practices of physicians and caregivers of children with neurologic and neurodevelopmental conditions — United States, 2011-12 influenza season. MMWR 2013 Sep 13;62(36):744-6
CDC. Prevention and control of influenza with vaccines: interim recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013. MMWR 2013 May 10;62(18):356
CDC. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season. MMWR 2012 Aug 17;61(32):613-8
CDC. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2013-2014. MMWR 2013 (published online Sep 20)
Cheng AC, Holmes M, Irving LB, et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study. PLoS One 2013 Jul 16;8(7):e68760
Cowling BJ, Ng S, Ma ESK, et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Clin Infect Dis 2012 Sep 1;55(5):695-702
De Serres G, Skowronski DM, Wu XW, et al. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill 2013;18(37):pii=20585
DiazGranados CA, Denis M, Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 2012 Dec 17;31(1):49-57
Dolan GP, Clarkson M, Sokal R, et al. Vaccination of health care workers to protect patients at increased risk for acute respiratory disease. Emerg Infect Dis 2012 Aug;18(8):1225-34
Domachowske JB, Pankow-Culot H, Bautista M, et al. A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years. J Infect Dis 2013 207(12):1878-87
Eames KTD, Brooks-Pollock E, Paolotti D, et al. Rapid assessment of influenza vaccine effectiveness: analysis of an internet-based cohort. Epidemiol Infect 2012 Jul;140(7):1309-15
Foppa IM, Haber M, Ferdinands JM, et al. The case test-negative design for studies of the effectiveness of seasonal influenza vaccine. Vaccine 2013 Jun 26;31(20):3104-9
Gorse GJ, Falsey AR, Fling JA, et al. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age. Vaccine 2013 May 1;31(19):2358-65
Greenberg DP, Robertson CA, Noss MJ, et al. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults. Vaccine 2013 Jan 21;31(5):770-6
Honda H, Sato Y, Yamazaki A, et al. A successful strategy for increasing the influenza vaccination rate of healthcare workers without a mandatory policy outside of the United States: a multifaceted intervention in a Japanese tertiary care center. Infect Control Hosp Epidemiol 2013 (published online Sep 19)
Hung IFN, Levin Y, To KKW, et al. Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain. Vaccine 2012 Oct 5;30(45):6427-35
Janjua NZ, Skowronski DM, De Serres G, et al. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross protection against major and minor variants. J Infect Dis 2012 Jun 15;205(12):1858-68
Jimenez-Jorge S, de Mateo S, Delgado-Sanz C, et al. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination. BMC Infect Dis 2013 Sep 22;13:441
Jimenez-Jorge S, Savulescu C, Pozo F, et al. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine 2012 May 21;30(24):3595-602
Kafatos G, Pebody R, Andrews N, et al. Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study. Influenza Other Respi Viruses 2013 (published online Sep 16)
Karve S, Meier G, Davis KL, et al. Influenza-related health care utilization and productivity losses during seasons with and without a match between the seasonal and vaccine virus B lineage. Vaccine 2013 Jul 18;31(33):3370-88
Kelly H, Steffens I. Complexities in assessing the effectiveness of inactivated influenza vaccines. (Editorial) Euro Surveill 2013 Feb 14;18(7):pii=20403
Kelly NR, Kromelis MR, Jordan D, et al. Feasibility of delivering influenza vaccine to household contacts of pediatric patients in a residents' continuity clinic. Am J Infect Control 2012 Sep;40(7):627-31
Kennedy ED, Ahluwalia IB, Ding H, et al. Monitoring seasonal influenza vaccination coverage among pregnant women in the United States. Am J Obstet Gynecol 2012 Sep;207(3 Suppl):S9-16
Kharbanda EO, Vazquez-Benitez G, Shi WX, et al. Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink. Am J Obstet Gynecol 2012 Sep;207(3 Suppl)S47-51
Kieninger D, Sheldon E, Lin WY, et al. Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged >=18 years. BMC Infect Dis 2013 Jul 24;13:343
Kissling E, Valenciano M, Larrauri A, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicenter case-control study. Euro Surveill 2013 Jan 31;18(5):pii=20390
Koseki N, Kaiho M, Kikuta H, et al. Comparison of the clinical effectiveness of zanamivir and laninamivir octanoate for children with influenza A(H3N2) and B in the 2011-2012 season. Influenza Other Respi Viruses 2013 (published online Aug 19)
Kostova D, Reed C, Finelli L, et al. Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005-2011. PLoS One 2013 Jun 19;8(6):e66312
Langley JM, Scheifele DW, Quach C, et al. Safety and immunogenicity of 2010-11 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study. Vaccine 2012 May 14;30(23):3389-94
MacIntosh VH, Tastad KJ, Eick-Cost AA, et al. Mid-season influenza vaccine effectiveness 2011-2012: a Department of Defense Global, Laboratory-based, Influenza Surveillance System case-control study estimate. Vaccine 2013 Mar 25;31(13):1651-5
Mahmud SM, Caeseele PV, Hammond G, et al. No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada. Emerg Infect Dis 2012 May;18(5):801-10
Marra F, Young F, Richardson K, et al. A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events. Influenza Other Respi Viruses 2013 Jul;7(4):584-603
Martinez-Baz I, Martinez-Artola V, Reina G, et al. Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study. BMC Public Health 2013 Mar 6;13:191
McMenamin J, Andrews N, Robertson C, et al. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. Euro Surveill 2013 Jan 31;18(5):pii=20393
Moro PL, Arana J, Cano M, et al. Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the vaccine adverse event reporting system, 1 July 2010-31 December 2010. Clin Infect Dis 2012 Jun 1;54(11):1608-14
Muramatsu M, Yoshida R, Miyamoto H, et al. Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice. PLoS One 2013 Aug 16;8(8):e71534
Nelson MI, Vincent AL, Kitikoon P, et al. The evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011. J Virol 2012 (published online Jun 13)
Newcomer SR, Hambidge SJ, McClure DL, et al. Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children. Vaccine 2013 Aug 20;31(37):3894-8
Ng S, Fang VJ, Ip DKM, et al. Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children. J Infect Dis 2013 (published online Aug 1)
Pabst LJ, Chaves SS, Weinbaum C. Trends in compliance with two-dose influenza vaccine recommendations among children aged 6 months through 8 years. Vaccine 2013 Jun 28;31(31):3116-20
Pebody RG, Andrews N, Fleming DM, et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiol Infect 2013 Mar;141(3):620-30
Pebody RG, Andrews N, McMenamin J, et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill 2013 Jan 31;18(5):pii=20389
Phillips CJ, Woolpert T, Sevick C, et al. Comparison of the effectiveness of trivalent inactivated influenza vaccine and live, attenuated influenza vaccine in preventing influenza-like illness among US military service members, 2006-2009. Clin Infect Dis 2013 Jan 1;56(1):11-9
Puig-Barbera J, Diez-Domingo J, Arnedo-Pena A, et al. Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study. Vaccine 2012 Aug 24;30(39):5714-20
Rondy M, Puig-Barbera J, Launay O, et al. 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalization: pooled analysis from a European network of hospitals: a pilot study. PLoS One 2013 Apr 2;8(4):e59681
Salmon DA, Proschan M, Forshee R, et al. Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 2013 Apr 27;381(9876):1461-8
Skowronski DM, Janjua NZ, De Serres G, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-11 season. Clin Infect Dis 2012 Aug 1;55(3):332-42
Skowronski DM, Janjua NZ, De Serres G, et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro Surveill 2013 Jan 31;18(5):pii=20394
Stockwell MS, Martinez RA, Hofstetter A, et al. Timeliness of 2009 H1N1 vaccine coverage in a low-income pediatric and adolescent population. Vaccine 2013 Apr 12;31(16):2103-7
Sullivan SG, Kelly H. Late season interim estimates of influenza vaccine effectiveneEuross reliably predict end of season estimates in Victoria, Australia, 2007 to 2012. Euro Surveill 2013 Oct 10;18(41):pii=20605
Sundaram ME, McClure DL, VanWormer JJ, et al. Influenza vaccination is not associated with detection of non-influenza respiratory viruses in seasonal studies of influenza vaccine effectiveness. Clin Infect Dis 2013 Sep 15;57(6):789-93
Talbot TR, Babcock H, Cotton D, et al. The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): guidance from the Society for Healthcare Epidemiology of America (SHEA). Infect Control Hosp Epidemiol 2012 Oct;33(10):981-3
Thompson M, Sokolow LZ, Almendares O, et al. Effectiveness of non-adjuvanted monovalent A(H1N1)pdm09 vaccines for preventing RT-PCR-confirmed pandemic influenza hospitalizations: case-control study of children and adults at ten U.S. Influenza Surveillance Network sites. Clin Infect Dis 2013 (published online Aug 15)
Treanor JJ. Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012 Oct 1;55(7):951-9
Tricco AC, Chit A, Soobiah C, et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 2013 Jun 25;11:153
Valenciano M, Kissling E, I-MOVE case-control study team. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill 2013 Feb 14;18(7):pii=20400
Van Buynder PG, Konrad S, Van Buynder JL, et al. The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. Vaccine 2013 (published online Aug 6)
WHO Writing Group. Strengthening the influenza vaccine virus selection and development process: outcome document of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conferences (CICG) Geneva, Switzerland, 7 to 9 December 2011. Vaccine 2013 Jul 11;31(32):3209-21
Widgren K, Magnusson M, Hagstam P, et al. Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden. Euro Surveill 2013 Apr 11;18(15):pii=20447
Zhou L, Su Q, Xu Z, et al. Seasonal influenza vaccination coverage rate of target groups in selected cities and provinces in China by season (2009/10 to 2011/12). PLoS One 8(9): e73724. doi:10.1371/journal.pone.0073724
